Fill out the form to get your white papers document.

*
*
*
*
*

How Drug Manufacturers, Health Systems and Payers Can Collaborate More Closely

As healthcare reimbursements move from fee-for-service (FFS) to value-based payments, the pressure has never been greater to demonstrate the quality of patient care. In response, drug manufacturers, health systems and payers are simultaneously seeking new ways to improve value and patient outcomes, while protecting reimbursements...